Arama

EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 17 results

Ranking

Release Date Sort Sort Article Type

Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China

Zhu ZHEN-HUA, Huang DE-QIANG, Xie YONG, Liu LIN-LIN, Lu NONG-HUA

(Turk J Gastroenterol 2013; 24: 5-9) DOI: 10.4318/tjg.2013.0525

Abstract Full Text ( PDF) Related Articles

Duodenal ulcer healing and Helicobacter pylori eradication with 10 day omeprazole amoxicillin and clarithromycin therapy

Mehmet CİNDORUK, Ahmet GÖRDÜLÜ, Şükrü DUMLU, Zeynep AKI, Selahattin ÜNAL

(Turk J Gastroenterol 1997; 8: 322-325)

Abstract Full Text ( PDF) Related Articles

One-week triple her therapies for Helicobacter pylori eradication

Ahmet AYDIN, Galip ERSÖZ, Müge TUNÇYÜREK, Hanefi ÇAVUŞOĞLU

(Turk J Gastroenterol 1998; 9: 40-45)

Abstract Full Text ( PDF) Related Articles

Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China

Duodenal ulcer healing and Helicobacter pylori eradication with 10 day omeprazole amoxicillin and clarithromycin therapy

One-week triple her therapies for Helicobacter pylori eradication

Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey

Efficacy of combination therapy with omeprazole, amoxicillin and clarithromycin for treatment of patients with Helicobacter pylori associated gastritis and duodenal ulcer disease

Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases

The effect of different dosage and duration of lansoprazole-clarithromycin- amoxycillin combination on Helicobacter pylori eradication

Ranitidine bismuth citrate based dual and triple therapies in Helicobacter pylori eradication

Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori

An effective and economic approach for the eradication of Helicobacter Pylori:omeprazole and two antibiotic combination

Prevelance of helicobacter pylori infection among Turkish living in or near Stutgart Germany, and the effect of triple therapy (pantoprazole-clarithomycin-metronidzole) on Helicobacter pylori infection

Comparison of FISH, RFLP and agar dilution methods for testing clarithromycin resistance of Helicobacter pylori

Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study

CLARITHROMYCIN-OMEPRAZOLE COMBINATION IN HELICOBACTER PYLORI ERADICATION

Unacceptable Antibiotic Resistance Rates for Helicobacter pylori in Turkey: Something Must Change

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains